Published in Cell Cycle on October 28, 2016
Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users. Nutrients (2017) 0.75
Metformin: a metabolic modulator. Oncotarget (2017) 0.75
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2009) 19.65
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell (2010) 15.20
IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 7.95
Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell (2000) 5.79
CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature (2009) 4.83
Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep (2002) 4.13
PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell (2012) 3.83
SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell (2013) 3.24
Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell (2011) 2.88
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70
Metabolic regulation of epigenetics. Cell Metab (2012) 2.55
The Emerging Hallmarks of Cancer Metabolism. Cell Metab (2016) 2.32
A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell (2014) 2.27
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov (2013) 2.11
Oncometabolites: linking altered metabolism with cancer. J Clin Invest (2013) 1.78
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab (2014) 1.74
Oncometabolites-driven tumorigenesis: From genetics to targeted therapy. Int J Cancer (2014) 1.60
Metformin for aging and cancer prevention. Aging (Albany NY) (2010) 1.51
Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer Metab (2014) 1.34
p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem (2010) 1.34
Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab (2015) 1.32
Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics (2012) 1.14
Acetyl-CoA carboxylase regulates global histone acetylation. J Biol Chem (2012) 1.13
Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metab (2015) 1.11
Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A (2014) 1.10
Gerosuppressant metformin: less is more. Aging (Albany NY) (2011) 1.08
Metabolic Control of Longevity. Cell (2016) 1.07
Metabostemness: a new cancer hallmark. Front Oncol (2014) 1.05
Acetylated histone H3K56 interacts with Oct4 to promote mouse embryonic stem cell pluripotency. Proc Natl Acad Sci U S A (2013) 1.04
Metformin as a Tool to Target Aging. Cell Metab (2016) 1.03
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis. PLoS Biol (2015) 1.02
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr Opin Cell Biol (2015) 1.01
Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells. J Biol Chem (2007) 1.01
Mitonuclear communication in homeostasis and stress. Nat Rev Mol Cell Biol (2016) 1.01
The rate of glycolysis quantitatively mediates specific histone acetylation sites. Cancer Metab (2015) 0.99
Metformin: do we finally have an anti-aging drug? Cell Cycle (2013) 0.98
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions. Mol Cell (2015) 0.97
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread. Oncotarget (2015) 0.97
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors. Oncotarget (2015) 0.93
Metabolic mechanisms of epigenetic regulation. ACS Chem Biol (2013) 0.92
Metformin for cancer and aging prevention: is it a time to make the long story short? Oncotarget (2015) 0.92
Geroncogenesis: metabolic changes during aging as a driver of tumorigenesis. Cancer Cell (2014) 0.92
Metabostemness: Metaboloepigenetic reprogramming of cancer stem-cell functions. Oncoscience (2014) 0.91
Metabolic control of methylation and acetylation. Curr Opin Chem Biol (2015) 0.86
Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites. Cell Cycle (2014) 0.86
Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia. Nat Commun (2016) 0.86
Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process. Cell Signal (2014) 0.85
Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions. PLoS One (2015) 0.85
Oncometabolites: tailoring our genes. FEBS J (2015) 0.85
Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription. Trends Biochem Sci (2016) 0.85
Histone H3 lysine 27 acetylation is altered in colon cancer. Clin Proteomics (2014) 0.84
Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor. Nucleic Acids Res (2015) 0.84
One-carbon metabolism and epigenetics: understanding the specificity. Ann N Y Acad Sci (2015) 0.84
Oncometabolic Nuclear Reprogramming of Cancer Stemness. Stem Cell Reports (2016) 0.83
The role of mutation of metabolism-related genes in genomic hypermethylation. Biochem Biophys Res Commun (2014) 0.82
Energy metabolism and metabolic sensors in stem cells: the metabostem crossroads of aging and cancer. Adv Exp Med Biol (2014) 0.82
IGF1 regulates PKM2 function through Akt phosphorylation. Cell Cycle (2015) 0.82
Metabolic control of cancer cell stemness: Lessons from iPS cells. Cell Cycle (2015) 0.81
Diverse Activities of Histone Acylations Connect Metabolism to Chromatin Function. Mol Cell (2016) 0.81
Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers. Oncotarget (2016) 0.79
The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs. Curr Pharm Des (2015) 0.78
Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome. Oncotarget (2016) 0.77
Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents. Oncotarget (2016) 0.76
Activation of the methylation cycle in cells reprogrammed into a stem cell-like state. Oncoscience (2016) 0.76